Cipla Ltd update on USFDA inspection at Cipla's manufacturing facility in Goa

Cipla Ltd had earlier announced regarding the United States Food and Drug Administration (USFDA) inspection of its Goa manufacturing facility, The Company has received a communication from the USFDA that the classification of Company's said facility continues to be as Official Action Indicated ("OAI"). USFDA may continue to withhold product approvals from this facility till the outstanding observations are resolved.

The Company has an ongoing derisking plan in place for new product approvals. The Company will work closely with the USFDA and is committed to address these within the stipulated time.

Shares of Cipla Limited was last trading in BSE at Rs. 1107.20 as compared to the previous close of Rs. 1103.70. The total number of shares traded during the day was 34310 in over 1572 trades.

The stock hit an intraday high of Rs. 1123.40 and intraday low of 1099.00. The net turnover during the day was Rs. 38081024.00.

Source : Equity Bulls

Keywords

Cipla INE059A01026 USFDA OfficialActionIndicated GoaFacility